Stockreport

Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only br [Read more]